(Press-News.org) Researchers at UBC and BC Cancer have developed a new artificial intelligence (AI) model that can accurately predict if a person receiving cancer care will require mental health services during their treatment journey.
The AI uses natural language processing and advanced neural networks to analyze an oncologist’s notes from their first consultation appointment with a patient. While these appointments are typically highly focused on a patient’s medical history and treatment options, the AI picks up on subtle clues hidden within the medical language that suggest a patient may benefit from early psychiatric or counselling interventions.
According to findings recently published in Communications Medicine, the AI can predict with greater than 70 per cent accuracy whether a patient will see a psychiatrist or counsellor within a year. It is the first time AI has been used to predict mental health outcomes from non-psychiatric medical documents.
“Battling cancer can be a harrowing experience, affecting not only our bodies, but our minds and emotions,” said principal investigator Dr. John-Jose Nunez, a psychiatrist and clinical research fellow with the UBC Mood Disorders Centre and BC Cancer. “These findings demonstrate the tremendous potential of AI to essentially act as a personal assistant to oncologists, enhancing patient care by helping identify mental health needs sooner and ensuring more patients receive the support they need.”
Mental health has been shown to have a profound impact on treatment outcomes and quality of life for people with cancer. On average, patients with significant depression and anxiety have poorer survival outcomes. Experts believe it’s because these patients have more difficulties following through with treatment recommendations and tolerating side effects.
The Canadian Association of Psychosocial Oncology estimates that approximately 15 per cent of cancer patients require psychiatric services, while another 45 per cent would benefit from seeing a counsellor. However, barriers such as stigma, lack of awareness of services, and difficulties diagnosing mental health conditions can prevent people from accessing psychosocial care.
As a next step, Dr. Nunez hopes to work with oncologists and patients to explore how such an AI tool could be implemented to improve early access to these important services.
“Perhaps the AI prompts the oncologist to talk with their patient about psychiatric services, or it could trigger an email to patients with a tailored list of available services,” said Dr. Nunez. “There are a lot of possibilities, but it’s important that we work with health professionals and patients to ensure the AI is meeting people where they need it.”
The AI was developed by an interdisciplinary team with expertise in computer science, medical oncology and psychiatry. The researchers trained and tested the model using data from 59,800 patients across all six BC Cancer sites located across geographically diverse regions of British Columbia.
To protect privacy, patient data remained stored securely at BC Cancer and was presented anonymously. Unlike patient chart reviews by human research assistants, the new AI approach has the added benefit of maintaining complete confidentiality of patient records.
The researchers also made significant advances in AI interpretability, developing a new technique that allowed them to peer inside the model to see how it was making predictions. Common themes arose, with certain key words and topics suggesting a greater need for mental health services: family history of cancer, patterns of alcohol or substance use, and certain types of aggressive cancers and treatment strategies.
“Neural models have been commonly called black boxes because it’s difficult to interpret how they arrive at an answer,” said study co-author Dr. Raymond Ng, a professor in UBC’s department of computer science. “These cutting-edge techniques allow us to unravel these mysteries for multiple documents at a time, which could further empower researchers and clinicians to understand the complex intersections of oncology and mental health.”
The team envisions expanding the tool’s use beyond oncology to other fields of medicine where psychosocial factors significantly impact patient outcomes. This could pave the way for a broader application of AI in healthcare, targeting early intervention across various medical disciplines.
END
AI can tell if a patient battling cancer needs mental health support
It is the first time AI has been used to predict mental health outcomes from non-psychiatric medical documents.
2024-05-02
ELSE PRESS RELEASES FROM THIS DATE:
ISSCR announces Hong Kong, SAR as location for its 2025 Annual Meeting
2024-05-02
The world’s leading stem cell scientists will convene in Hong Kong, SAR, 11-14 June 2025 for the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting, illuminating the future of stem cell science and highlighting the most compelling research and clinical advances of the year. The meeting is co-sponsored by The University of Hong Kong, The Chinese University of Hong Kong, and Hong Kong University of Science and Technology. The Hong Kong Innovation and Technology Commission and the Hong Kong Convention and Exhibition Centre provided significant support to enable the ISSCR to bring its hallmark event to the city of ...
Zoology: First report of wound treatment by a wild animal using a medicinal plant
2024-05-02
A wild male Sumatran orangutan (Pongo abelii) has been observed applying chewed leaves from Akar Kuning (Fibraurea tinctoria) — a climbing plant used in traditional medicine to treat wounds and conditions such as dysentery, diabetes, and malaria — to a wound on his cheek. The findings, which are published in Scientific Reports, represent the first report of suspected wound treatment by a wild animal using a plant with known medicinal properties.
Prior to this study, multiple ...
Longer interval between first colonoscopy with negative findings for colorectal cancer and repeat colonoscopy
2024-05-02
About The Study: This cohort study found that for the population without a family history of colorectal cancer (CRC), the 10-year interval between colonoscopy screenings for individuals with a first colonoscopy with findings negative for CRC could potentially be extended to 15 years. A longer interval between colonoscopy screenings could be beneficial in avoiding unnecessary invasive examinations.
Authors: Mahdi Fallah, M.D., Ph.D., of the German Cancer Research Center in Heidelberg, is the corresponding ...
Smoking cessation after initial treatment failure with varenicline or nicotine replacement
2024-05-02
About The Study: For individuals who smoked but did not achieve abstinence after treatment with varenicline, increasing the dosage enhanced abstinence versus continuing, whereas for nonabstainers initially treated with combined nicotine replacement therapy, a dosage increase or switch to varenicline enhanced abstinence and may be viable rescue strategies.
Authors: Paul M. Cinciripini, Ph.D., of the University of Texas MD Anderson Cancer Center in Houston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.4183)
Editor’s Note: Please see the article ...
How the brain’s arousal center helps control visual attention too
2024-05-02
The locus coeruleus (LC) is a small region of the brainstem that produces norepinephrine, a chemical with powerful effects on arousal and wakefulness which plays an important role in the body’s response to stress or panic. Now, research from the University of Chicago shows it plays a specific role in visual sensory processing as well.
In a new study published in Neuron, neuroscientists artificially increased neuronal activity in the LC by briefly shining light on genetically modified neurons. They saw that this manipulation selectively enhanced performance in non-human primates performing a visual attention task, underscoring the crucial role that attention plays in sensory ...
Increasing doses of varenicline or nicotine replacement helps persistent smokers quit
2024-05-02
HOUSTON ― For most smokers, quitting on the first attempt is likely to be unsuccessful, but a new study from The University of Texas MD Anderson Cancer Center found patients were more likely to quit if their cessation regimen was altered and doses were increased. Researchers also found that varenicline, a cessation medication, was more effective than combined nicotine replacement therapy (CNRT), such as patches or lozenges.
The study, published today in JAMA, revealed smokers who failed to quit with varenicline in the trial’s first phase were seven times more likely to quit by the end of the second phase if varenicline ...
Artificial intelligence yields promising results for advancing coronary angiography
2024-05-02
Long Beach, Calif. – May 2, 2024 – New insights from the AI-ENCODE study showed artificial intelligence (AI) successfully allowed the automated extraction of key functional and physiological data from routine angiograms. The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
Coronary angiography is a widely used diagnostic procedure for identifying coronary artery disease (CAD), performed in over one million patients annually in the United States. Currently, data extracted from coronary angiograms are confined to detecting blockages in the coronary arteries. However, AI technology ...
Non-fasting pre-procedural strategy for cardiac catheterization significantly improved patient well-being and satisfaction
2024-05-02
Long Beach, Calif. – May 2, 2024 – New data from the CALORI Cardiac Catheterization trial shows significant improvement in patient well-being and satisfaction without compromising safety after implementation of a liberal non-fasting strategy prior to a cardiac catheterization procedures. The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
More than one million cardiac catheterizations are performed each year in the U.S. to diagnose heart problems. The risk of complications ...
Gene therapy treatment increasing body’s signal for new blood vessel growth shows promise
2024-05-02
Long Beach, Calif. – May 2, 2024 – Final 12-month data from the EXACT trial demonstrates safety and efficacy results for a vascular endothelial growth factor (VEGF) gene therapy treatment for patients who have advanced coronary artery disease (CAD). The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
CAD, also known as coronary heart disease or ischemic heart disease, affects about 20.5 million U.S. adults – making it the most common type of heart disease in the ...
Novel score system accurately identifies lesions reducing risk of PCI complications
2024-05-02
Long Beach, Calif. – May 2, 2024 – New data demonstrated that a left main (LM) bifurcation-specific novel scoring system (LM V-RESOLVE), based on three simple baseline angiographic findings, could help to rapidly discriminate lesions at risk of side branch (SB) occlusion during LM bifurcation percutaneous coronary intervention (PCI) – reducing risk during the procedure. The results from the prospective trial were presented today as late-breaking science at the Society for Cardiovascular Angiography & Interventions (SCAI) ...
LAST 30 PRESS RELEASES:
New route to ‘quantum spin liquid’ materials discovered for first time
Chang’e-6 basalts offer insights on lunar farside volcanism
Chang’e-6 lunar samples reveal 2.83-billion-year-old basalt with depleted mantle source
Zinc deficiency promotes Acinetobacter lung infection: study
How optogenetics can put the brakes on epilepsy seizures
Children exposed to antiseizure meds during pregnancy face neurodevelopmental risks, Drexel study finds
Adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer
Scientists transform blood into regenerative materials, paving the way for personalized, blood-based, 3D-printed implants
Maarja Öpik to take up the position of New Phytologist Editor-in-Chief from January 2025
Mountain lions coexist with outdoor recreationists by taking the night shift
Students who use dating apps take more risks with their sexual health
Breakthrough idea for CCU technology commercialization from 'carbon cycle of the earth'
Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group
Depression research pioneer Dr. Philip Gold maps disease's full-body impact
Rapid growth of global wildland-urban interface associated with wildfire risk, study shows
Generation of rat offspring from ovarian oocytes by Cross-species transplantation
Duke-NUS scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness
Compound metalens achieves distortion-free imaging with wide field of view
Age on the molecular level: showing changes through proteins
Label distribution similarity-based noise correction for crowdsourcing
The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050
Diabetes medication may be effective in helping people drink less alcohol
US over 40s could live extra 5 years if they were all as active as top 25% of population
Limit hospital emissions by using short AI prompts - study
UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research
Fayetteville police positive about partnership with social workers
Optical biosensor rapidly detects monkeypox virus
New drug targets for Alzheimer’s identified from cerebrospinal fluid
Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment
Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H
[Press-News.org] AI can tell if a patient battling cancer needs mental health supportIt is the first time AI has been used to predict mental health outcomes from non-psychiatric medical documents.